A comparative, single blind, parallel group, non-crossover, multi-centric trial of Imidafenacin Tablets 0.1 mg, with Uritos Tablets, in-patients suffering from Overactive Bladder.
Phase of Trial: Phase III
Latest Information Update: 02 Sep 2016
At a glance
- Drugs Imidafenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 04 Sep 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
- 04 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
- 12 Feb 2010 New trial record